Statistics for Feasibility of the vaccine development for SARS-CoV-2 and other viruses using the shell disorder analysis
Total visits
views | |
---|---|
Feasibility of the vaccine development for SARS-CoV-2 and other viruses using the shell disorder analysis | 120 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
Goh2020Feasibility.pdf | 164 |
java.util.UUID:664877c3-beed-4be8-abf5-baf331139e8b | 58 |
java.util.UUID:0c1ea944-789a-4270-99a6-02361f8c257f | 5 |
java.util.UUID:17ae90f3-7d7e-4388-9cdf-2c41681d0f14 | 4 |
Top country views
views | |
---|---|
United States | 89 |
Canada | 3 |
Germany | 3 |
Sweden | 3 |
China | 2 |
Singapore | 2 |
Czechia | 1 |
France | 1 |
Italy | 1 |
Malaysia | 1 |
Russia | 1 |
Thailand | 1 |
Top city views
views | |
---|---|
Wilmington | 36 |
Fairfield | 12 |
Cambridge | 7 |
San Francisco | 6 |
Houston | 5 |
Ann Arbor | 3 |
Lanham | 3 |
Stockholm | 3 |
Baltimore | 2 |
Chicago | 2 |
Toronto | 2 |
Augusta | 1 |
Beijing | 1 |
Gunzenhausen | 1 |
Jacksonville | 1 |
Kansas City | 1 |
Kiez | 1 |
Lake Mary | 1 |
Laval | 1 |
Moscow | 1 |
Munich | 1 |
Paris | 1 |
Putignano | 1 |
Seremban | 1 |
Singapore | 1 |
Slapanice | 1 |
Tak | 1 |
Tampines | 1 |
Washington | 1 |
White Plains | 1 |